Skip to main content
Erschienen in: Pediatric Nephrology 3/2007

01.03.2007 | Original Article

A missense mutation in factor I (IF) predisposes to atypical haemolytic uraemic syndrome

verfasst von: Joyce Geelen, Koen van den Dries, Anja Roos, Nicole van de Kar, Corrie de Kat Angelino, Ina Klasen, Leo Monnens, Lambertus van den Heuvel

Erschienen in: Pediatric Nephrology | Ausgabe 3/2007

Einloggen, um Zugang zu erhalten

Abstract

A genetic predisposition involving complement regulatory genes has become evident in some patients with atypical HUS. In this paper, a patient with a heterozygous missense mutation in factor I (IF) is described. Although the serum level of IF was normal, a mild functional defect in the alternative pathway of complement could be demonstrated in the affected members of the family. After an episode of atypical HUS, chronic renal insufficiency started at the age of 15 months. Recurrence of HUS, with loss of the renal transplant, occurred twice in this patient. The recurrence of HUS in the graft was not reflected by haematological abnormalities (haemolysis, thrombocytopenia). One additional transplant was lost due to arterial thrombosis of the renal artery. This report confirms the gloomy outcome of renal transplants in patients with an IF deficiency. New therapies should be evaluated in these patients.
Literatur
1.
Zurück zum Zitat Dragon-Durey MA, Fremeaux-Bacchi V (2005) Atypical haemolytic uraemic syndrome and mutations in complement regulator genes. Springer Semin Immunopathol 27:359–374CrossRef Dragon-Durey MA, Fremeaux-Bacchi V (2005) Atypical haemolytic uraemic syndrome and mutations in complement regulator genes. Springer Semin Immunopathol 27:359–374CrossRef
2.
Zurück zum Zitat Tsiftsoglu SA, Willis AC, Li P, Chen X, Mitchell DA, Rao Z, Sim RB (2005) The catalytically active serine protease domain of human complement factor I. Biochemistry 44:6239–6249CrossRef Tsiftsoglu SA, Willis AC, Li P, Chen X, Mitchell DA, Rao Z, Sim RB (2005) The catalytically active serine protease domain of human complement factor I. Biochemistry 44:6239–6249CrossRef
3.
Zurück zum Zitat Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215CrossRef Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215CrossRef
4.
Zurück zum Zitat Seelen MA, Roos A, Wieslander J, Mollnes TE, Sjoholm AG, Wurzner R, Loos M, Tedesco F, Sim RB, Garred P, Alexopoulos E, Turner MW, Daha MR (2005) Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA. J Immunol Methods 296:187–198CrossRef Seelen MA, Roos A, Wieslander J, Mollnes TE, Sjoholm AG, Wurzner R, Loos M, Tedesco F, Sim RB, Garred P, Alexopoulos E, Turner MW, Daha MR (2005) Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA. J Immunol Methods 296:187–198CrossRef
5.
Zurück zum Zitat Catterall CF, Lyons A, Sim RB, Day AJ, Harris TJR (1987) Characterization of the primary amino acid sequence of human complement control protein Factor I from an analysis of cDNA clones. Biochem J 242:849–856CrossRef Catterall CF, Lyons A, Sim RB, Day AJ, Harris TJR (1987) Characterization of the primary amino acid sequence of human complement control protein Factor I from an analysis of cDNA clones. Biochem J 242:849–856CrossRef
6.
Zurück zum Zitat Gonzales-Rubio C, Ferreira-Cerdan A, Ponce IM, Arpa J, Fontan G, Lopez-Trascasa (2001) Complement factor I deficiency associated with recurrent meningitis coinciding with menstruation. Arch Neurol 58:1923–1928CrossRef Gonzales-Rubio C, Ferreira-Cerdan A, Ponce IM, Arpa J, Fontan G, Lopez-Trascasa (2001) Complement factor I deficiency associated with recurrent meningitis coinciding with menstruation. Arch Neurol 58:1923–1928CrossRef
7.
Zurück zum Zitat Krediet T, Asghar SS, Koomen GCH, Venneker CT, Struijk DG, Arisz L (1991) Effect of renal failure on complement C3d levels. Nephron 59:41–45CrossRef Krediet T, Asghar SS, Koomen GCH, Venneker CT, Struijk DG, Arisz L (1991) Effect of renal failure on complement C3d levels. Nephron 59:41–45CrossRef
8.
Zurück zum Zitat Lundberg L, Johansson G, Karlsson L, Stegmayr BG (1994) Complement activation is influenced by the membrane material, design of the dialyser, sterilising method and type of dialysate. Nephrol Dial Transplant 9:1310–1314PubMed Lundberg L, Johansson G, Karlsson L, Stegmayr BG (1994) Complement activation is influenced by the membrane material, design of the dialyser, sterilising method and type of dialysate. Nephrol Dial Transplant 9:1310–1314PubMed
9.
Zurück zum Zitat Vyse TJ, Spath PJ, Davies KA, Morley BJ, Philippe P, Athanassiou P, Giles CM, Walport MJ (1994) Hereditary complement factor I deficiency. Q J Med 87:385–401 Vyse TJ, Spath PJ, Davies KA, Morley BJ, Philippe P, Athanassiou P, Giles CM, Walport MJ (1994) Hereditary complement factor I deficiency. Q J Med 87:385–401
10.
Zurück zum Zitat Genel F, Sjoholm AG, Skattum L, Truedson L (2005) Complement factor I deficiency associated with recurrent infections, vaculitis and immune complex glomeronephritis. Scand J Infect Dis 37:615–618CrossRef Genel F, Sjoholm AG, Skattum L, Truedson L (2005) Complement factor I deficiency associated with recurrent infections, vaculitis and immune complex glomeronephritis. Scand J Infect Dis 37:615–618CrossRef
11.
Zurück zum Zitat Fremeaux-Bacchi V, Dragon-Durey MA, Blouin J, Vigneau C, Kuypers D, Boudailliez B, Loirat C, Rondeau E, Fridman WH (2004) Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome. J Med Genet 41:e84CrossRef Fremeaux-Bacchi V, Dragon-Durey MA, Blouin J, Vigneau C, Kuypers D, Boudailliez B, Loirat C, Rondeau E, Fridman WH (2004) Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome. J Med Genet 41:e84CrossRef
12.
Zurück zum Zitat Kavanagh D, Kemp EJ, Mayland E, Winney RJ, Duffield JS, Warwick G, Richards A, Ward R, Goodship JA, Goodship TH (2005) Mutations in complement factor I predispose to the development of atypical haemolytic uremic syndrome. J Am Soc Nephrol 16:2150–2155CrossRef Kavanagh D, Kemp EJ, Mayland E, Winney RJ, Duffield JS, Warwick G, Richards A, Ward R, Goodship JA, Goodship TH (2005) Mutations in complement factor I predispose to the development of atypical haemolytic uremic syndrome. J Am Soc Nephrol 16:2150–2155CrossRef
13.
Zurück zum Zitat Caprioli J, Noris M, Brioschi S, Pianetti G, Castelletti F, Bettinaglio P, Mele C, Bresin E, Cassis L, Gamba S, Porrati F, Bucchioni S, Monteferrante G, Fang CJ, Liszewski MK, Kavanagh D, Atkinson JP, Remuzzi G, International Registry of Recurrent and Familial HUS/TTP (2006) Genetics of HUS: the impact of MCP, CFH and IF mutations on clinical presentation, response to treatment, and outcome. Blood 108:1267–1279CrossRef Caprioli J, Noris M, Brioschi S, Pianetti G, Castelletti F, Bettinaglio P, Mele C, Bresin E, Cassis L, Gamba S, Porrati F, Bucchioni S, Monteferrante G, Fang CJ, Liszewski MK, Kavanagh D, Atkinson JP, Remuzzi G, International Registry of Recurrent and Familial HUS/TTP (2006) Genetics of HUS: the impact of MCP, CFH and IF mutations on clinical presentation, response to treatment, and outcome. Blood 108:1267–1279CrossRef
14.
Zurück zum Zitat Esparza-Gordillo J, Goicoechea de Jorge E, Buil A, Carreras Berges L, Lopez-Trascasa M, Sanchez-Corral P, Rodriguez de Cordoba S (2005) Predisposition to atypical haemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32. Hum Mol Genet 14:703–712CrossRef Esparza-Gordillo J, Goicoechea de Jorge E, Buil A, Carreras Berges L, Lopez-Trascasa M, Sanchez-Corral P, Rodriguez de Cordoba S (2005) Predisposition to atypical haemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32. Hum Mol Genet 14:703–712CrossRef
15.
Zurück zum Zitat Pratt JR, Basheer SA, Sacks SH (2002) Local synthesis of complement C3 regulates acute renal transplant rejection. Nat Med 8:582–587CrossRef Pratt JR, Basheer SA, Sacks SH (2002) Local synthesis of complement C3 regulates acute renal transplant rejection. Nat Med 8:582–587CrossRef
16.
Zurück zum Zitat Zhou W, Farrar CA, Abe K, Pratt J, Marsh J, Wang Y, Stahl G, Sacks S (2000) Predominant role for c5b-9 in renal ischemia/reperfusion injury. J Clin Invest 105:1363–1371CrossRef Zhou W, Farrar CA, Abe K, Pratt J, Marsh J, Wang Y, Stahl G, Sacks S (2000) Predominant role for c5b-9 in renal ischemia/reperfusion injury. J Clin Invest 105:1363–1371CrossRef
17.
Zurück zum Zitat Rasmussen JM, Teisner B, Jepsen HH, Svehag SE, Knudsen F, Kirstein H, Buhl M (1988) Three cases of factor I deficiency: the effect of treatment with plasma. Clin Exp Immunol 74:131–136 Rasmussen JM, Teisner B, Jepsen HH, Svehag SE, Knudsen F, Kirstein H, Buhl M (1988) Three cases of factor I deficiency: the effect of treatment with plasma. Clin Exp Immunol 74:131–136
18.
Zurück zum Zitat Hill A, Hillmen P, Richards SJ, Elebute D, Marsh JC, Chan J, Mojcik CF, Rother RP (2005) Sustained response and long-term safety of eculizumab in paroxysmal nocturnal hemoglobinuria. Blood 106:2559–2565CrossRef Hill A, Hillmen P, Richards SJ, Elebute D, Marsh JC, Chan J, Mojcik CF, Rother RP (2005) Sustained response and long-term safety of eculizumab in paroxysmal nocturnal hemoglobinuria. Blood 106:2559–2565CrossRef
19.
Zurück zum Zitat Pickering MC, Warren J, Rose KL, Carlucci F, Wang Y, Walport MJ, Cook HT, Botto M (2006) Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice. Proc Natl Acad Sci USA 103:9649–9654CrossRef Pickering MC, Warren J, Rose KL, Carlucci F, Wang Y, Walport MJ, Cook HT, Botto M (2006) Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice. Proc Natl Acad Sci USA 103:9649–9654CrossRef
Metadaten
Titel
A missense mutation in factor I (IF) predisposes to atypical haemolytic uraemic syndrome
verfasst von
Joyce Geelen
Koen van den Dries
Anja Roos
Nicole van de Kar
Corrie de Kat Angelino
Ina Klasen
Leo Monnens
Lambertus van den Heuvel
Publikationsdatum
01.03.2007
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Nephrology / Ausgabe 3/2007
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-006-0320-2

Weitere Artikel der Ausgabe 3/2007

Pediatric Nephrology 3/2007 Zur Ausgabe

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Häufigste Gründe für Brustschmerzen bei Kindern

06.05.2024 Pädiatrische Diagnostik Nachrichten

Akute Brustschmerzen sind ein Alarmsymptom par exellence, schließlich sind manche Auslöser lebensbedrohlich. Auch Kinder klagen oft über Schmerzen in der Brust. Ein Studienteam ist den Ursachen nachgegangen.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärztinnen und Psychotherapeuten.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.